Timster, please stop posting facts, it’s not big, it’s not clever and it’s not funny.
What is funny is the latest rumour, have you heard that the evil masterminds at Boohoo have trained a bunch of pigeons and that’s going to be our distribution network? What’s worse is they’re only paying them 3.5 teaspoons of seed a day. To make things worse, you should hear about their living conditions. They’re keeping them cooped up.
Probably worth noting that Sona in Canada has tripled just based on initial results from its test strip development. I wouldn’t disagree with your timescale for avct, but I think it’ll bag in the next few weeks as the performance details emerge. They also have a BAMS product on the way, but it won’t have as much of an impact. Also, they’ve had it independently verified that their affimers block the virus, so at any point a major pharma might decide to take a punt on them. I’d shove avct to 2nd on your list currently and by sept way out in front.
Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents is pleased to announce that the first Affimer-based rapid test strips to detect SARS-COV-2 spike protein have been developed and evaluated by Avacta's partners at Cytiva (formerly GE Healthcare Life Sciences) and show positive initial performance data.
Would you look at that, they’re already working with them...
The Company is working with these manufacturers to compress the normal manufacturing, clinical validation and regulatory timelines in order to bring a product to market as quickly as possible.
Wrong Punter. It’s about statistics not sentiment. The sentiment will follow the money, there is an exponentially increasing need for testing and GDR have an excellent product. When the sales start rolling in, the share price will reflect that.
Yeah, we’ve caught up slightly but you’re ahead so it’s a handy reference for us. It wasn’t the best performance to be fair, he seemed quite unsure and lacked a bit of confidence in progress. Ultimately I’m sure the world needs both to succeed so here’s hoping for a good result for both companies, but mainly us, obviously ;-)
RE: The UK gov budget has to be for antigen testing06 Jul 2020 15:42
Well Awacta have £10m put aside to ramp up production from our side, news on manufacturers is due soon and I’m sure more will be added as time goes on. To answer your question, no, we won’t be able to keep up with global demand. Not a terrible problem to have... a licence to print cash and not enough printers.